Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Gross Margin
Clarus Therapeutics Holdings Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 1.1m USD |
| Gross Margin |
79%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 748B USD |
| Gross Margin |
80%
|
| Country | DK |
| Market Cap | 4.1T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 367.4B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 333.6B USD |
| Gross Margin |
75%
|
| Country | UK |
| Market Cap | 188.8B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 187.2B CHF |
| Gross Margin |
73%
|
| Country | CH |
| Market Cap | 181.6B CHF |
| Gross Margin |
74%
|
| Country | US |
| Market Cap | 162.7B USD |
| Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Clarus Therapeutics Holdings Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Clarus Therapeutics Holdings Inc's most recent financial statements, the company has Gross Margin of 78.6%.
You don't have any saved screeners yet
